Karen Brown

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

Christian T. Ruff, Robert P. Giugliano, Eugene Braunwald et al. · The Lancet · 2015 · 389 citations

Anti-factor Xa Activity, Edoxaban Dose, Clinical Epidemiology +6

Graphic Canadian Cigarette Warning Labels and Adverse Outcomes: Evidence from Canadian Smokers

David Hammond, Geoffrey T. Fong, Paul McDonald et al. · American Journal of Public Health · 2004 · 325 citations · Full text

The COMPASS study: a longitudinal hierarchical research platform for evaluating natural experiments related to changes in school-level programs, policies and built environment resources

Scott T. Leatherdale, Karen Brown, Valerie Carson et al. · BMC Public Health · 2014 · 305 citations · Full text

Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate

Hamim Zahir, Karen Brown, Alexander G. Vandell et al. · Circulation · 2014 · 250 citations

Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: A sequestration mechanism in metabolic regulation

Dennis Farrelly, Karen Brown, Aaron Tieman et al. · Proceedings of the National Academy of Sciences · 1999 · 152 citations · Full text

Liver Gk Activity, Glucose Homeostasis, Metabolic Remodeling +24